New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 17, 2018 - The FDA announced the approval of Amgen’s Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults.
Download PDF
Return to publications
